Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CanadaBis Capital Inc V.CANB

Alternate Symbol(s):  CNADF

Healthcare
CanadaBis Capital Inc. is a vertically integrated Canadian cannabis company. The Company’s principal business is the production and sale of recreational cannabis and cannabis extracts. The Company operates through three segments: Cultivation and wholesale, Retail and Extract. The Cultivation and wholesale segment is engaged in cultivating and distributing cannabis and cannabis products to and through, provincial liquor and cannabis boards, which are subsequently sold to end consumers. Its Retail segment is involved in the sale of cannabis and cannabis related products to end consumers on premise owned and operated by the Company. Its Extract segment provides cannabinoid extraction services for the Company and also to other licensed producers. The Company’s subsidiaries include Stigma Pharmaceuticals Inc., 1998643 Alberta Ltd., Full Spectrum Labs Ltd., 2103157 Alberta Ltd., and Goldstream Cannabis Inc.


TSXV:CANB - Post by User

CanadaBis Capital Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Post by cigars.moneyon Mar 18, 2021 1:48pm
158 Views
Post# 32827244

Not to many with sales mutliple of 6 equal market cap!!

Not to many with sales mutliple of 6 equal market cap!!Market cap of around 25 million, Retail store open april 2019, Indicative collection. Has help increase with other sales from stigma grow to a total of 4.4 million in full fiscal year 2020 Revenue Increased by 535% in the Fourth Quarter Compared to Q3 with a Dramatic increase over Q1 2019 with Sequential Quarterly Revenue Growth
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities